Group One Trading’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-120,100
| Closed | -$1.1M | – | 9107 |
|
|
2021
Q2 | $1.1M | Buy |
120,100
+75,200
| +167% | +$437K | ﹤0.01% | 3301 |
|
|
2021
Q1 | $223K | Buy |
44,900
+39,700
| +763% | +$192K | ﹤0.01% | 4913 |
|
|
2020
Q4 | $22K | Sell |
5,200
-3,700
| -42% | -$15.1K | ﹤0.01% | 5483 |
|
|
2020
Q3 | $38K | Buy |
8,900
+5,700
| +178% | +$23.8K | ﹤0.01% | 4821 |
|
|
2020
Q2 | $14K | Buy |
+3,200
| New | +$14.3K | ﹤0.01% | 5015 |
|
|
2020
Q1 | – | Sell |
-17,500
| Closed | -$148K | – | 5989 |
|
|
2019
Q4 | $148K | Buy |
17,500
+17,000
| +3,400% | +$133K | ﹤0.01% | 3377 |
|
|
2019
Q3 | $3K | Buy |
+500
| New | +$3.67K | ﹤0.01% | 4888 |
|
|
2019
Q2 | – | Sell |
-3,700
| Closed | -$34K | – | 5610 |
|
|
2019
Q1 | $34K | Buy |
+3,700
| New | +$37.6K | ﹤0.01% | 3777 |
|
|
2017
Q4 | – | Sell |
-100
| Closed | -$1K | – | 5409 |
|
|
2017
Q3 | $1K | Buy |
+100
| New | +$750 | ﹤0.01% | 4733 |
|
|
2015
Q4 | – | Sell |
-8,000
| Closed | -$42K | – | 5268 |
|
|
2015
Q3 | $42K | Sell |
8,000
-2,000
| -20% | -$12.3K | ﹤0.01% | 3631 |
|
|
2015
Q2 | $68K | Buy |
+10,000
| New | +$70.9K | ﹤0.01% | 3359 |
|
|
2015
Q1 | – | Sell |
-500
| Closed | -$4K | – | 5369 |
|
|
2014
Q4 | $4K | Buy |
+500
| New | +$4.24K | ﹤0.01% | 4570 |
|
Other funds holding KIN
Group One Trading's KIN Position: Q3 2021 in Review
Group One Trading sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 30,976 shares — an estimated $284K sold.
Group One Trading first reported a position in KIN in Q4 2014 and held it in 10 quarters. The position peaked at $284K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Group One Trading reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Group One Trading sold 30,976 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $284K.
- Group One Trading first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 10 quarters.
- Group One Trading's Kindred Biosciences, Inc. position peaked at $284K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.